RIVASTIGMINE VIATRIS 9.5 mg/24 hours, medicated transdermal patch 30 patches in individual sachets, CIP 3400930240311
Active ingredients: Rivastigmine
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch30 patches in individual sachets, CIP 3400930240311transdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIVASTIGMINE VIATRIS 9,5 mg/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 30 sachet(s) papier polytéréphtalate (PET) polyéthylène aluminium LasPolD avec fermeture de sécurité enfant de 1 dispositif(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66442631CIP73024031CIP133400930240311Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVASTIGMINEdispositif | 13,8 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.